Cenk Uygur
@TheYoungTurks·6.5M subscribers·72.8K videos
FDA Approves New Drug For DMD Patients Despite Its Ineffectiveness
Posted
October 3, 2016
Views
40,707
Likes
859
Comments
161
Engagement
2.51%
October 3, 2016
40,707
859
161
2.51%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
9:26Now PlayingRing of Fire's Mike Papantonio and Sam Seder discuss how the new drug designed for Duchenne muscular dystrophy patients, has been pushed onto the market by the FDA, despite the fact that their own scientists question the effectiveness of the new blockbuster drug from Sarepta Therapeutics. SUBSCRIBE to Ring Of Fire
Subscribe to the ROF Podcast for more great content
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
